dpp-4 inhibitor and glp-1 receptor agonist combination not recommended ada Comparison of agonists inhibitors Dipeptidyl peptidase 4 inhibitors in

Because of the shortage of GLP-1 prescription drugs, the FDA allowed compounding pharmacies to make copycat versions of Wegovy and Zepbound that were much cheaper- $129 per month versus the brand name price that went upwards of $1,300

Knapen (86) also reported through follow-up studies that the pancreatic tumor risk in patients treated with GLP-1RA for a long period of time was not significantly different

In addition, all currently available GLP-1R therapies are peptide agonists, most of which require subcutaneous administration [140]

Huixing L, Di F, Daoquan P

Questions and Answers - Safety Requirements for Victoza (liraglutide)

In these individuals, the anti-inflammatory effects may provide additional benefit beyond glycemic control